ExodusPoint Capital Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $493K | Buy |
109,227
+12,882
| +13% | +$58.1K | ﹤0.01% | 1091 |
|
|
2025
Q1 | $447K | Buy |
+96,345
| New | +$447K | ﹤0.01% | 1073 |
|
|
2024
Q4 | – | Sell |
-393,586
| Closed | -$2.09M | – | 1581 |
|
|
2024
Q3 | $2.09M | Buy |
393,586
+86,267
| +28% | +$457K | 0.01% | 670 |
|
|
2024
Q2 | $1.15M | Buy |
307,319
+42,041
| +16% | +$157K | 0.01% | 857 |
|
|
2024
Q1 | $1.87M | Buy |
265,278
+35,474
| +15% | +$250K | 0.01% | 631 |
|
|
2023
Q4 | $1.3M | Sell |
229,804
-389,444
| -63% | -$2.2M | 0.01% | 671 |
|
|
2023
Q3 | $2.97M | Sell |
619,248
-50,247
| -8% | -$241K | 0.03% | 509 |
|
|
2023
Q2 | $4.59M | Buy |
669,495
+407,902
| +156% | +$2.79M | 0.04% | 415 |
|
|
2023
Q1 | $2.04M | Buy |
+261,593
| New | +$2.04M | 0.02% | 780 |
|